Health Products Type I ? Class 1/Type I = High risk (serious health hazard). Class 2/Type II = Moderate risk. Class 3/Type III = Low risk. Updated 2025-07-08

NRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tablets

See all recalls from NRA-AMLODIPINE →
Share: Facebook X / Twitter WhatsApp

Recalled Product

NRA-AMLODIPINE 5MG


✅ What Should You Do?

  1. 🛑 Stop using this product immediately and set it aside.
  2. Follow the instructions from the issuing agency (see below).
  3. 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
  4. 📋 Report an adverse reaction to Health Canada MedEffect
Looking for a safe alternative? Search Amazon Canada for NRA-AMLODIPINE 5MG →

Hazard / Issue

Product safety

Issued by

Drugs and health products

⚠️ What You Should Do

Check your medication bottle to ensure it only contains NRA-AMLODIPINE 5 mg tablets.If your bottle contains any round tablets, which are not the correct shape, or if you're unsure, return the bottle to your pharmacy for a replacement.If you are unable to get a replacement immediately, continue to take your medication as directed, but do not take the round tablets as these are the wrong medication.Contact your health care professional if you are dizzy, have unusually low blood pressure or slow heartbeats. If you are unable to access a health care professional and you are experiencing these symptoms, call 911.If you have questions about this recall, contact Nora Pharma Inc. by calling their Quality Assurance Department at 450-904-2355 or by emailing info@norapharma.ca.Report any health product-related side effects or complaints to Health Canada.Additional information for health professionals:Health care professionals, such as pharmacists, should check packages and bottles labelled NRA-AMLODIPINE 5 mg (amlodipine besylate) before dispensing to make sure they do not contain Metoprolol Succinate prolonged-release 12.5 mg tablets. Report any unusual bottles or other issues to the company and Health Canada.
View official government recall